Immunotherapy for glioblastoma well tolerated; survival gains observed

A phase one study of 11 patients with glioblastoma who received injections of an investigational vaccine therapy and an approved chemotherapy showed the combination to be well tolerated while also resulting in unexpectedly significant survival increases, researchers report.
Source: Feed4

Leave a Reply

Your email address will not be published. Required fields are marked *